Previous 10 | Next 10 |
home / stock / emhtf / emhtf news
VICTORIA, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided updates on its various cultivation and processing initiatives. “With the first 1.1 million square foot (25 acre) green...
Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary Cannabis stocks saw a slight rebound last week. The Horizons Marijuana Life Sciences Index ETF ( OTC:HMLSF ) rose 3.2% and the ETFM...
Riaz Bandali has driven innovation, sales, and profitability in a number of global life science companies Emerald also adds Chief Commercial Officer VICTORIA, British Columbia, July 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TS...
The growth of the cannabis industry has made it possible for companies to offer investment opportunities through the major listing exchanges in Canada. Previously known as the Canadian Venture Exchange, the TSX Venture Exchange is the sibling listing to the larger Toronto Stock Exchange...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Libsyn , Spotify , Stitcher or Apple Podcasts . By Rena Sherbill Today, I am very happy to be joined by Allan Rewak, vice president, communications and stakeholder relations at Emerald Health...
VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has received its cultivation license from Health Canada for the 12-acre outdoor grow area at its new organic cannabis operation in Metro Vanco...
Emerald Health Therapeutics (TSXV:EMH) (OTCQX:EMHTF) stock is falling despite a company announcement earlier that should have pleased investors. EMHTF stock is down 3.39% and selling for $1.71 USD on the OTC at present. EMHTF Stock Falls The Canadian cannabis producer owns 50% of a...
July 11, 2019 FN Media Group Presents Safehaven.com Market Commentary London – July 11, 2019 – Not too long ago, cannabis was just the feel-good supplement of choice for a young generation, looking to blow off steam. But intense research on the plant has led...
VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc.’s (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has achieved its full production ...
VANCOUVER, British Columbia, July 10, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 9,960 40-ml units of its SYNC 25 CBD oil to Alberta and Saskatchewan. The Emerald-branded Indica-dominant CBD oil offers consumers...
News, Short Squeeze, Breakout and More Instantly...
Emerald Health Therapeutics Company Name:
EMHTF Stock Symbol:
OTCMKTS Market:
Emerald Health Therapeutics Website:
Emerald Health Therapeutics Inc (EMHTF) is expected to report for Q3 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announced today that its Plan of Arrangement with Skye Bioscience, Inc. ("Skye") has closed and that it has entered into agreements to di...
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") and Skye Bioscience, Inc. (OTCQB: SKYE...